
    
      This is an open-label, multicenter study to describe the immunological response and safety of
      repeat administration of an adolescent/adult-formulation tetanus-diphtheria-acellular
      pertussis Tdap vaccine (ADACELÂ®), 10 years following initial administration of Tdap vaccine.
    
  